Philip van der Wees has been appointed Professor of Allied Health Sciences at the Radboud university medical center with effect from 1 June 2018.The focus of the Chair is value-driven allied health care in interdisciplinary networks. Allied health professionals, such as physical therapists, occupational therapists, speech therapists and dietitians, make an important contribution to promoting recovery and coping l with a disease or health condition in daily life. The research and education within the new Chair focuses on quality improvement and implementation of allied health care in interdisciplinary networks; and secondly to unravel mechanisms of effectiveness and to evaluate new technologies and treatment strategies for allied health care.
Philip van der Wees (Benthuizen, 1966) studied Physical Therapy at The Hague University of Applied Sciences and obtained his Master of Science in Human Movement Sciences at the VU Amsterdam in 1994. In 2009 he obtained his PhD at Maastricht University on research into the development and implementation of guidelines in physiotherapy.
Philip is member of the theme Healthcare improvement science and has worked as senior researcher at the Radboud Institute of Health Sciences, department IQ healthcare, of Radboud university medical center since 2013. Since 2017 he has worked as adjunct professor at the School of Medicine and Health Sciences; Department of Clinical Research and Leadership, George Washington University, Washington, DC.
The Chair of Allied Health Sciences is a collaboration between the departments IQ healthcare, Rehabilitation and Orthopedics (Radboud university medical center) and the HAN University of Applied Sciences.
Related news items
TP53 allelic state is critical for diagnostic and prognostic precision in blood cancer12 August 2020
An international study, in which Joop Jansen participated, shows that a double mutaton in TP53 gene deteriotes the prognosis of a rare form of blood cancer. If there is only one mutation or no mutation, then the prognosis is better.read more
BCG vaccine is safe with no increased risk of COVID-19 symptoms says Mihai Netea11 August 2020
The BCG vaccine has a general stimulatory effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.read more
650,000 Euro funding for research into the phasing out of medication for leukaemia patients30 July 2020
With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.read more
Increased role of patients after bowel cancer treatment30 July 2020
Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.read more
ERC Proof of Concept grant received by Ronald van Rij30 July 2020
Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.read more
Hypatia fellowship Call is open30 July 2020
The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.read more